ザルトリウス・ジャパン Official site

Creating groundbreaking new drugs from monoclonal antibodies targeting GPCRs.

We publish information related to the research and development of antibodies targeting GPCRs.

This document introduces an interview with NBI Health Research Institute (Sapporo City), a biotech venture specialized in the development of monoclonal antibody drugs targeting G protein-coupled receptors (GPCRs). It includes efforts to produce antibodies against GPCRs, including G proteins. [Contents] ■ Controlling information transmission related to diseases ■ Capturing proteins exposed on the extracellular surface ■ High-speed flow cytometry as the key ■ The frontier spirit of Hokkaido blossoms *For more details, please refer to the PDF document or feel free to contact us.

Introduction page for the ultra-high-speed flow cytometer (official site)

basic information

For more details, please refer to the PDF document or feel free to contact us.

Price range

Delivery Time

Applications/Examples of results

For more details, please refer to the PDF document or feel free to contact us.

Related Videos

Creating groundbreaking new drugs from monoclonal antibodies targeting GPCRs.

OTHER

Recommended products

Distributors

Sartorius is a leading global company that contributes to biopharmaceutical research and the biopharmaceutical industry, established in 1870. Sartorius's laboratory products/services division meets the needs of researchers and technicians engaged in research and development and quality control in the medical industry and various other sectors by providing innovative laboratory equipment and consumables. Our products and technologies are designed to simplify our customers' operations and contribute to accelerating research and improving operational efficiency. *Biotechnology-related products can be found at the following URL: https://premium.ipros.jp/sartorius-stedim/